Preoperative single-dose camrelizumab and/or microwave ablation in women with early-stage breast cancer: A window-of-opportunity trial
Innovative treatments are still needed to reduce metastatic disease for early-stage breast cancer. Pan et al. found that local microwave ablation combined with camrelizumab showed a favorable local effect and systemic immune response in the treatment of early-stage breast cancer, and the long-term effect of this strategy is worth investigating.